Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma
Journal Title: Pancreas – Open Journal - Year 2016, Vol 1, Issue 2
Abstract
Despite significant effort and research funds, Pancreatic Ductal Adenocarcinoma (PDAC) remains one of the deadliest diseases. This cancer is characterized by a distinct desmoplastic reaction that constitutes 80% of the tumor volume. Accumulating evidences suggests that the stromal compartment in which the cancer cells are embedded contributes to many clinical characteristics of pancreatic cancer. The stromal compartment is comprised of abundant extracellular matrix (ECM), fibroblasts, stellate cells, immune cells, nerve cells, growth factors and cytokines. To date, desmoplastic reaction components have been shown not only to contribute to the growth and metastasis of pancreatic cancer but also to chemotherapy resistance. Therefore, further assessment of stroma-targeted therapies and their translation into clinical situation may open a new era in pancreatic cancer management.
Authors and Affiliations
Ughur Aghamaliyev
Keywords
Related Articles
- EP ID EP556685
- DOI 10.17140/POJ-1-107
- Views 198
- Downloads 0
Delayed Onset Post-ERCP Pancreatitis (DOPE-P)
Post Endoscopic retrograde cholangiopancreatography (ERCP) Pancreatitis (PEP) is defined as new onset or worsening of pain abdomen after ERCP with an elevation of pancreatic enzymes (amylase/lipase) more than 3 times upp...
Pancreatic Leaks and Fistulae: Pathophysiological Principles
Pancreatic fistula is one of the common complications that may arises after upper gastrointestinal surgery, acute pancreatitis and, more rarely, abdominal traumas. The treatment is mainly based on conservative therapy. H...
Genetic Therapy for Pancreatic Cancer: Is it the Future?
Although surgery is still the only curative therapy for pancreatic cancer, oncological therapies have started to be more and more promising. We firstly have to consider two important points. The first one is that surgery...
Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma
Despite significant effort and research funds, Pancreatic Ductal Adenocarcinoma (PDAC) remains one of the deadliest diseases. This cancer is characterized by a distinct desmoplastic reaction that constitutes 80% of the t...
PD-1/PD-L1 Blockade: A New Promising Therapy for the Treatment of Pancreatic Cancer?
Programmed cell death protein 1 (PD-1), a member of the CD28 family, is an immune-checkpoint receptor expressed on a variety of immune cells, such as T-cells, monocytes, B-cells, dendritic cells, and tumor-infiltrating l...